Aurora Spine posted $2.43 million in second quarter revenue, according to an Aug. 26 news release.
Four notes:
1. Second quarter revenue was up 53.5 percent year-over-year.
2. Proprietary products made up 64.5 percent of sales in the second quarter, compared to 47 percent during the same period last year.
3. The company saw increased expenses in the second quarter as the company prepares to launch new products under FDA review.
4. CEO Trent Northcutt said, "Our second quarter was another improved quarter for Aurora, as the company continued to get back to pre-COVID-19 revenue levels. That said, while pandemic headwinds still persist, we continue to be highly focused on developing more proprietary products."